Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae015 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Jennifer H Ku und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA. Hauptthemen laut MEDLINE: Latent Tuberculosis, Delivery of Health Care, Integrated, Mass Screening. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, CDC, NIH HHS.
Abstract (Originalsprache)
Background
Tuberculosis (TB) is a public health threat, with >80% of active TB in the United States occurring due to reactivation of latent TB infection (LTBI). We may be underscreening those with high risk for LTBI and overtesting those at lower risk. A better understanding of gaps in current LTBI testing practices in relation to LTBI test positivity is needed.
Methods
This study, conducted between 1 January 2008 and 31 December 2019 at Kaiser Permanente Southern California, included individuals aged ≥18 years without a history of active TB. We examined factors associated with LTBI testing and LTBI positivity.
Results
Among 3 816 884 adults (52% female, 37% White, 37% Hispanic, mean age 43.5 years [standard deviation, 16.1]), 706 367 (19%) were tested for LTBI, among whom 60 393 (9%) had ≥1 positive result. Among 1 211 971 individuals who met ≥1 screening criteria for LTBI, 210 025 (17%) were tested for LTBI. Factors associated with higher adjusted odds of testing positive included male sex (1.32; 95% confidence interval, 1.30–1.35), Asian/Pacific Islander (2.78, 2.68–2.88), current smoking (1.24, 1.20–1.28), diabetes (1.13, 1.09–1.16), hepatitis B (1.45, 1.34–1.57), hepatitis C (1.54, 1.44–1.66), and birth in a country with an elevated TB rate (3.40, 3.31–3.49). Despite being risk factors for testing positive for LTBI, none of these factors were associated with higher odds of LTBI testing.
Conclusions
Current LTBI testing practices may be missing individuals at high risk of LTBI. Additional work is needed to refine and implement screening guidelines that appropriately target testing for those at highest risk for LTBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, California, USA.
- Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
- Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama, USA.
- Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, California, USA.
ORCID-Profile: Jennifer H Ku, Sara Y Tartof
Förderung
- NIAID NIH HHS
- CDC
- NIH HHS
- National Institutes of Health
Zitieren
APA
Ku, J. H., Fischer, H., Qian, L. X., Li, K., Skarbinski, J., Shaw, S., Bruxvoort, K. J., Lewin, B. J., Spence, B. C., & Tartof, S. Y. (2024). Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae015
Vancouver
Ku JH, Fischer H, Qian LX, Li K, Skarbinski J, Shaw S, et al. Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae015
BibTeX
@article{Ku2024,
author = {Ku, Jennifer H and Fischer, Heidi and Qian, Lei X and Li, Kris and Skarbinski, Jacek and Shaw, Sally and Bruxvoort, Katia J and Lewin, Bruno J and Spence, Brigitte C and Tartof, Sara Y},
title = {Latent Tuberculosis Infection Testing Practices in a Large US Integrated Healthcare System},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae015}
}
EUVIMED